ResearcherAnhui Medical UniversityNo recent work listed

Le Ren

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5058823408. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. Last author DOI 10.3892/ol.2019.10627 ↗
The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.2147/tcrm.s154226 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yue Yu · 1 shared paper, 2018 · strength 0.17
- Paper The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma. DOI 10.2147/tcrm.s154226 ↗
Yue Yu · 1 shared paper, 2019 · strength 0.12
- Paper Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. DOI 10.3892/ol.2019.10627 ↗
Fei Ding · 1 shared paper, 2019 · strength 0.12
- Paper Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. DOI 10.3892/ol.2019.10627 ↗
Meng Gao · 1 shared paper, 2019 · strength 0.12
- Paper Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. DOI 10.3892/ol.2019.10627 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.